Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study
Not Applicable
Completed
- Conditions
- Upper Gastrointestinal Bleeding
- First Posted Date
- 2022-11-30
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- EnteraSense Limited
- Target Recruit Count
- 30
- Registration Number
- NCT05631639
- Locations
- 🇨🇿
Fakultní nemocnice Olomouc (FNOL), Olomouc, Czechia
🇨🇿Fakultní nemocnice Ostrava (FNO), Ostrava, Czechia
🇨🇿Institut klinické a experimentální medicíny (IKEM),, Prague, Czechia
Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -Healthy Volunteers Study
Not Applicable
Completed
- Conditions
- Upper Gastrointestinal Bleeding
- First Posted Date
- 2022-11-30
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- EnteraSense Limited
- Target Recruit Count
- 10
- Registration Number
- NCT05631652
- Locations
- 🇨🇿
Institut klinické a experimentální medicíny (IKEM),, Prague, Czechia
PillSense System for Detecting UGI Bleed
Not Applicable
Completed
- Conditions
- Upper Gastrointestinal BleedUGI BleedUpper Gastrointestinal Bleeding
- First Posted Date
- 2022-05-23
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- EnteraSense Limited
- Target Recruit Count
- 131
- Registration Number
- NCT05385224
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
News
No news found